Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MIF | P14174 | 13/20 | 0.74 |
| ▸ | TRPA1 | O75762 | 3/20 | 0.71 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.71 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.71 |
| ▸ | HPGD | P15428 | 1/20 | 0.71 |
| ▸ | CYP2E1 | P05181 | 1/20 | 0.48 |
| ▸ | CYP2A6 | P11509 | 1/20 | 0.48 |
| ▸ | HIF1A | Q16665 | 1/20 | 0.48 |
| ▸ | CYP2A13 | Q16696 | 1/20 | 0.48 |
| ▸ | EPAS1 | Q99814 | 1/20 | 0.48 |
| ▸ | GRIN2D | O15399 | 1/20 | 0.43 |
| ▸ | GRIN3B | O60391 | 1/20 | 0.43 |
| ▸ | GRIN1 | Q05586 | 1/20 | 0.43 |
| ▸ | GRIN2A | Q12879 | 1/20 | 0.43 |
| ▸ | GRIN2B | Q13224 | 1/20 | 0.43 |
| ▸ | GRIN2C | Q14957 | 1/20 | 0.43 |
| ▸ | GRIN3A | Q8TCU5 | 1/20 | 0.43 |
| ▸ | NAAA | Q02083 | 4/20 | 0.42 |
| ▸ | CYP1A1 | P04798 | 1/20 | 0.40 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.40 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL10651510 | 0.90 | MIF (0.62) | MIFTRPA1ALDH1A1CYP3A4HPGD | |
| SCHEMBL2107951 | 0.87 | MIF (0.65) | MIFTRPA1ALDH1A1CYP3A4HPGD | |
| SCHEMBL2341886 | 0.86 | MIF (0.62) | MIFTRPA1ALDH1A1CYP3A4HPGD | |
| SCHEMBL1551628 | 0.86 | MIF (1.00) | MIFTRPA1ALDH1A1CYP3A4HPGD | |
| SCHEMBL2338356 | 0.86 | MIF (0.62) | MIFTRPA1ALDH1A1CYP3A4HPGD | |
| SCHEMBL25333223 | 0.86 | MIF (0.69) | MIFTRPA1ALDH1A1CYP3A4HPGD | |
| SCHEMBL13623244 | 0.85 | MIF (0.61) | MIFTRPA1ALDH1A1CYP3A4HPGD | |
| SCHEMBL4776959 | 0.84 | MIF (0.68) | MIFTRPA1ALDH1A1CYP3A4HPGD | |
| Benzyl Isothiocyanate SCHEMBL44145 | 0.83 | MIF (1.00) | MIFTRPA1ALDH1A1CYP3A4HPGD | |
| Benzyl Isothiocyanate SCHEMBL27789925 | 0.83 | MIF (1.00) | MIFTRPA1ALDH1A1CYP3A4HPGD |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 166 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-112844472-B | Preparation method and application of chiral imidazole urea catalyst | 深圳市宝安区新材料研究院 | 2023-05-23 | — | — | CN | claimed |
| WO-2010065329-A2 | NANOPARTICLES FOR CANCER TREATMENT | THE BOARD OF REGENTS OF THE UNIVERSITY OF TEXAS SYSTEM (US) | 2010-06-10 | — | — | WO | claimed |
| US-20060241178-A1 | Compositions and methods for treating lung cancer | IMMUNEGUARD LLC (US) | 2006-10-26 | — | — | US | claimed |
| WO-2004060365-A1 | COMPOSITIONS AND METHODS FOR TREATING LUNG CANCER | AMERICAN HEALTH FOUNDATION (US) | 2004-07-22 | — | — | WO | claimed |
| EP-3861977-B1 | (METH)ACRYLATE, MONOMER COMPOSITION, MOLDED BODY, COMPOSITION FOR DENTAL MATERIAL, AND DENTAL MATERIAL | MITSUI CHEMICALS INC (JP) | 2026-05-06 | — | — | EP | disclosed |
| US-12605306-B2 | Method of manufacturing monomer composition, raw material composition, monomer composition, curable composition, and molded body | MITSUI CHEMICALS, INC. (JP) | 2026-04-21 | — | — | US | disclosed |
| US-12441821-B2 | (Meth)acrylate and use thereof | MITSUI CHEMICALS, INC. (JP) | 2025-10-14 | — | — | US | disclosed |
| US-12384870-B2 | Method for setting polymerization condition and method for manufacturing optical material | MITSUI CHEMICALS, INC. (JP) | 2025-08-12 | — | — | US | disclosed |
| US-20250122315-A1 | (METH)ACRYLATE AND USE THEREOF | MITSUI CHEMICALS, INC. (JP) | 2025-04-17 | — | — | US | disclosed |
| US-12275814-B2 | (Meth)acrylate, monomer composition, molded body, composition for dental material, and dental material | MITSUI CHEMICALS, INC. (JP) | 2025-04-15 | — | — | US | disclosed |
| US-12275813-B2 | Polymerizable composition for optical materials and application of same | MITSUI CHEMICALS, INC. (JP) | 2025-04-15 | — | — | US | disclosed |
| EP-3308928-B1 | METHOD FOR PRODUCING PLASTIC LENS AND USE OF A DEVICE FOR PRODUCING A PLASTIC LENS | MITSUI CHEMICALS INC (JP) | 2025-03-05 | — | — | EP | disclosed |
| EP-2065414-A1 | POLYMERIZATION CATALYST FOR POLYTHIOURETHANE OPTICAL MATERIAL, POLYMERIZABLE COMPOSITION CONTAINING THE CATALYST, POLYTHIOURETHANE RESIN OBTAINED FROM THE COMPOSITION, AND METHOD FOR PRODUCING THE RESIN | Mitsui Chemicals, Inc. (JP) | 2009-06-03 | — | — | EP | disclosed |
| US-7506977-B1 | Plastic spectacles lens | HOPNIC LABORATORY CO., LTD. (JP) | 2009-03-24 | — | — | US | disclosed |
| US-20060241178-A1 | Compositions and methods for treating lung cancer | IMMUNEGUARD LLC (US) | 2006-10-26 | — | — | US | disclosed |
| US-7009031-B2 | Composition for optical material | MITSUBISHI GAS CHEMICAL CO., INC. (JP) | 2006-03-07 | — | — | US | disclosed |
| WO-2004060365-A1 | COMPOSITIONS AND METHODS FOR TREATING LUNG CANCER | AMERICAN HEALTH FOUNDATION (US) | 2004-07-22 | — | — | WO | disclosed |
| US-20040024165-A1 | Composition for optical material | MITSUBISHI GAS CHEMICAL CO., INC. (JP) | 2004-02-05 | — | — | US | disclosed |
| EP-1319966-A1 | COMPOSITION FOR OPTICAL MATERIAL | MITSUBISHI GAS CHEMICAL COMPANY, INC. (JP) | 2003-06-18 | — | — | EP | disclosed |
| US-6472495-B1 | RESIN PRODUCED BY CURING THE COMPOSITION BY POLYMERIZATION HAS AN EXCELLENT IMPACT RESISTANCE AND OPTICAL PROPERTIES, AND IS SUITABLE AS AN OPTICAL MATERIAL. POLYMERS WITH SULFIDE, SELINIUM AND TELLURIUM | MITSUBISHI GAS CHEMICAL COMPANY, INC. (JP) | 2002-10-29 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20250122315-A1 | (METH)ACRYLATE AND USE THEREOF | TST, MMAB, BHMT2 | MIF 142/4885TRPA1 1453/4885ALDH1A1 144/4885 |
| US-12605306-B2 | Method of manufacturing monomer composition, raw material composition, monomer composition, curable composition, and molded body | ADH1A, ADH1C, ADH5 | MIF 1119/4885TRPA1 924/4885ALDH1A1 15/4885 |
| US-12275814-B2 | (Meth)acrylate, monomer composition, molded body, composition for dental material, and dental material | MMAB, CAD, ALG3 | MIF 1592/4885TRPA1 1876/4885ALDH1A1 369/4885 |
| US-12441821-B2 | (Meth)acrylate and use thereof | TST, MMAB, BHMT2 | MIF 142/4885TRPA1 1453/4885ALDH1A1 144/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.